Pixee Medical has received FDA 510(k) clearance for its augmented reality platform for total knee arthroplasty.
Knee+ NexSight improves surgical efficiency and adaptability in the operating room while providing robotic-level accuracy, according to an April 27 news release from Pixee Medical.
The system is fully compatible with most primary knee implants and personalized surgical approaches.
With the clearance, Pixee Medical will focus on the U.S. ASC market. Knee+ NexSight is designed to be integrated into ASC environments while streamlining workflows.
Knee+ NexSight received regulatory approval in Europe in February, and the initial cases have been successfully performed, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
